Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial

Jochen Wöhrle1*, MD; Sinisa Markovic1, MD; Wolfgang Rottbauer1, MD; Toshiya Muramatsu2, MD; Kazushige Kadota3, MD; Nicolás Vázquez-González4, MD; Jacob Odenstedt5, MD; Antonio Serra6, MD; David Antoniucci7, MD; Olivier Varenne8, MD; Shigeru Saito9, MD; William Wijns10, MD; on behalf of the CENTURY II Investigators

1. Department of Internal Medicine II, University of Ulm, Ulm, Germany; 2. Department of Cardiology, Saiseikai Yokohama City Eastern Hospital, Kanagawa, Japan; 3. Department of Cardiology, Kurashiki Central Hospital, Okayama, Japan; 4. Cardiac Catheteriza

Aims: CENTURY II is a prospective, multicentre, randomised, single-blind trial comparing the bioresorbable polymer sirolimus-eluting Ultimaster® stent (BP-SE

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

drug-eluting stentseverolimusstent thrombosisrandomised trialsirolimus

Coronary interventionsStents and scaffoldsTools, devices and techniques

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: a systematic review and meta-analysis